Cargando…
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation
The constant presence of the viral genome in Epstein-Barr virus (EBV)-associated gastric cancers (EBVaGCs) suggests the applicability of novel EBV-targeted therapies. The antiviral nucleoside drug, ganciclovir (GCV), is effective only in the context of the viral lytic cycle in the presence of EBV-en...
Autores principales: | Lee, Hyun Gyu, Kim, Hyemi, Kim, Eun Jung, Park, Pil-Gu, Dong, Seung Myung, Choi, Tae Hyun, Kim, Hyunki, Chong, Curtis R., Liu, Jun O., Chen, Jianmeng, Ambinder, Richard F., Hayward, S. Diane, Park, Jeon Han, Lee, Jae Myun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741585/ https://www.ncbi.nlm.nih.gov/pubmed/26427042 |
Ejemplares similares
-
Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011) -
Arsenicals, the Integrated Stress Response, and Epstein–Barr Virus Lytic Gene Expression
por: Lee, Jaeyeun, et al.
Publicado: (2021) -
Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir
por: Shirley, Courtney M, et al.
Publicado: (2012) -
Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis
por: Yap, Lee Fah, et al.
Publicado: (2022) -
Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009)